Page results
- 
                                    
                                                                            
UCLH treats a range of red cell blood disorders and anaemias.
 - 
                                    
                                                                            
UCLH is considered a centre of excellence in the management of patients with lymphoma.
 - 
                                    
                                                                            
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
 - 
                                    
                                                                            
Sickle cell disorder is the most common genetic (inherited) disorder in the United Kingdom.
 - 
                                    
                                                                            
This page is for patients who have been offered CT guided spinal steroid injections.
 - 
                                    
                                                                            
The Leishmaniasis Multidisciplinary Team (MDT) The leishmaniasis MDT aims to support clinicians around the UK in the investigation and management of patients with suspected or confirmed…
 - 
                                    
                                                                            
This page explains the options for sensitive handling of pregnancy tissue.
 - 
                                    
                                                                            
There is a lot of information on the internet; some of the stuff you find might not always be reliable so try to use websites you can trust. Here are some websites that have been recommended by…
 - 
                                    
                                                                            
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.